¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG Symposium&Workshop-Cervix, Vulva, Vagina TSC Workshop : 2024-02-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG Symposium&Workshop-Cervix, Vulva, Vagina TSC Workshop : 2024-02-24
±³À°ÀÏÀÚ : 2024-02-24
±³À°Àå¼Ò : °í·Á´ëÇб³ À¯±¤»çȦ

±³À°ÁÖÁ¦ : KGOG Symposium&Workshop-Cervix, Vulva, Vagina TSC Workshop

ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸

´ã´çÀÚ : ±èÇý¼÷
¿¬¶ôó : 02-512-5420

À̸ÞÀÏ : kelly.kim1436@gmail.com

±³À°Á¾·ù : »êºÎÀΰú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 09:00~09:15 Gynecologic Oncology Group Foundation ¹é¹ÎÇö(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 09:15~09:30 Gynecologic Cancer InterGroup ÀÌ»êÈñ(¿øÁֱ⵶¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 09:30~09:45 European Network of Gynaecological Oncological Trial groups (ENGOT) ÀÌÁöÇö(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 09:45~10:00 East Asian Gynecologic Oncology Trial Group (EAGOT)¡¡& Asia-Pacific Gynecologic Oncology Trials Group (APGOT) ÇÑ°æÈñ(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 10:20~10:35 Exploring Minimally Invasive Surgical Approaches in Cervical cancer Trials ±è¸í¼±(¼ººó¼¾Æ®º´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 10:35~10:50 Advancements in Low-Risk Early-Stage Cervical Cancer Trials ±èÀºÅÃ(°í½Å´ëÇб³º¹À½º´¿ø)

Åä·Ð 02¿ù 24ÀÏ À¯±¤»çȦ 10:50~11:05 Panel discussion including ROCC trial ¼Û¹ÎÁ¾±è±âµ¿ÀÓ¸íö(¿©Àǵµ¼º¸ðº´¿øºÐ´ç¼­¿ï´ëÇб³º´¿ø±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 11:50~12:10 Pembrolizumab in Cervical Cancer: KEYNOTE-826 Insights & Sub-Analyses at ASCO, ESGO, ASGO 2023 À̸¶¸®¾Æ(¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 13:10~13:25 KGOG 1047-Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr: A phase III, randomized controlled clinical trial (DEBULK Trial) ³ëÁÖ¿ø(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 13:25~13:40 KGOG 1036-Prospective-specimen-collection and retrospective blinded-evaluation study of HPV viral load to improve cervical cancer screening ±è¹ÎÁ¤(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 13:40~13:55 KGOG 1037-Retrospective-Impact of metformin of medication on survival outcome of cervical cancer ¹é¹ÎÇö(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 13:55~14:10 KRC-01-C01-A Phase 1/2 Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 Intratumoral Injection Combined with Radiotherapy in Patients with Locally Advanced Cervical Cancer Á¶¿¬¾Æ(°­³²¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 14:10~14:30 Revolutionizing Oncology : The Paradigm of Cancer Immunotherapy À̼öÁ¤(°æºÏ´ëÇб³Ä¥°îº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 14:30~14:50 Precision Therapeutics : Navigating the Landscape of Antibody Drug Conjugates ±è¼±¿µ(¼­¿ï¾Æ»êº´¿ø)

Åä·Ð 02¿ù 24ÀÏ À¯±¤»çȦ 14:50~15:10 Panel discussion ¹Ú¿µÇÑÃÖöÈƱè°Ç¹Î(ÇѸ²´ë¼º½Éº´¿ø»ï¼º¼­¿ïº´¿ø¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 15:30~15:45 KGOG 1028S-Radiotherapy versus Observation in intermediate risk patients after Radical hysterectomy for early cervical cancer : Ancillary analysis of a Korean Gynecologic Group Study ½É½ÂÇõ(°Ç±¹´ëº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 15:45~16:00 KGOG 1046-Adjuvant Chemotherapy Versus Radiotherapy For Postoperative Cervical Cancer : a phase 3 trial ½É½ÂÇõ(°Ç±¹´ëº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 16:00~16:15 KGOG 1044-Feasibility of HPV DNA and vaginal infectious disease detection in mail-delivered self obtained vaginal sample obtained by G+KitⓇ ±è¹®È«(¿øÀڷº´¿ø)

±³À°½Ã°£ 02¿ù 24ÀÏ À¯±¤»çȦ 16:15~16:30 KGOG 1038-Phase II study of Belotecan monotherapy in patients with recurrent of persistent cervical cancer À̱¤¹ü(°¡ÃµÀÇ´ë±æº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG Symposium&Workshop-Cervix, Vulva, Vagina TSC Workshop : 2024-02-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û â¿øƯ·Ê½Ãâ¿øÀÇ»çȸ ȸ¿ø¿¬¼ö±³À° : 2024-02-24
´ÙÀ½±Û 2024 ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ CISL : 2024-02-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20910 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 64 2024-05-28
20909 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 61 2024-05-28
20908 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 73 2024-05-28
20907 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 58 2024-05-28
20906 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 41 2024-05-28
20905 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 28 2024-05-28
20904 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 29 2024-05-28
20903 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 64 2024-05-28
20902 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 27 2024-05-28
20901 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 46 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 52 2024-05-28
20899 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 19 2024-05-28
20898 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 41 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 32 2024-05-28
20896 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 55 2024-05-28
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷